Oligonucleotide therapies for nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis (NASH) represents a severe disease subtype of nonalcoholic fatty liver disease (NAFLD) that is thought to be highly associated with systemic metabolic abnormalities. It is characterized by a series of substantial liver damage, including hepatocellular steatosis, inflamma...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2024-06-01
|
| Schriftenreihe: | Molecular Therapy: Nucleic Acids |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2162253124000714 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|